X @The Economist
Lilly(US:LLY) The Economist·2026-07-20 00:20The rise of GLP-1s has transformed Eli Lilly—and the pharma industry as a whole. We explain why investors now value the company more like a tech giant than a drugmaker https://t.co/KY3LKd7U4O ...